Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.362, 2002-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The pros and cons of Rx-to-OTC switching of drugs in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. :
The pros and cons of Rx-to-OTC switching of drugs in the US
Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. :
The return of Tysabri to the market in the US?
Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. :
Screening for proteinuria warranted in the US?
Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. :
Screening for proteinuria warranted in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 444, 2004-01 ,pp. :